Judith C. W. Marsh

Overview

Best Publications

• Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.

  Peter Hillmen;Claire Hall;Judith C W Marsh;Modupe Elebute

  872
  Citations

• Guidelines for the diagnosis and management of adult aplastic anaemia.

  Sally B Killick;Nick Bown;Jamie Cavenagh;Inderjeet Dokal

  738
  Citations

• Guidelines for the diagnosis and management of aplastic anaemia

  Judith C. W. Marsh;Sarah E. Ball;Jamie Cavenagh;Phil Darbyshire

  702
  Citations

• In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

  Panagiotis D Kottaridis;Donald W Milligan;Rajesh Chopra;Ronjon Chakraverty

  611
  Citations

• A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction.

  Howard A. Pearson;Jeffrey S. Lobel;Samuel A. Kocoshis;J. Lawrence Naiman

  530
  Citations

• The use of 7-amino actinomycin D in identifying apoptosis : Simplicity of use and broad spectrum of application compared with other techniques

  N. J. Philpott;A. J. C. Turner;J. Scopes;M. Westby

  476
  Citations

• Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working Party

  A. Bacigalupo;J. Hows;E. Gluckman;C. Nissen

  475
  Citations

• Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

  A. Sureda;P. Bader;S. Cesaro;P. Dreger

  435
  Citations

• Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

  Andrea Bacigalupo;Ronald Brand;Rosi Oneto;Barbara Bruno

  389
  Citations

• Progressive Telomere Shortening in Aplastic Anemia

  Sarah E. Ball;Frances M. Gibson;Siân Rizzo;Jennifer A. Tooze

  364
  Citations

• Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.

  Hubert Schrezenmeier;Jakob R. Passweg;Judith C. W. Marsh;Andrea Bacigalupo

  358
  Citations

• Allogeneic stem-cell transplantation using a reduced- intensity conditioning regimen has the capacity to produce durable remissions and long-term disease- free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

  Sudhir Tauro;Charles Craddock;Karl Peggs;Gulnaz Begum

  317
  Citations

• TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.

  Austin Gladston Kulasekararaj;Alexander E. Smith;Syed Mian;Azim M. Mohamedali

  302
  Citations

• Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.

  J. Marsh;H. Schrezenmeier;P. Marin;O. Ilhan

  279
  Citations

• Growth of human umbilical-cord blood in longterm haemopoietic cultures

  J.M. Hows;J.C.W. Marsh;T. Luft;L. Coutinho

  277
  Citations

• The EBMT activity survey: 1990-2010.

  J R Passweg;H Baldomero;A Gratwohl;M Bregni

  271
  Citations

• The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.

  David I Marks;Richard Lush;Jamie Cavenagh;Donald W Milligan

  269
  Citations

• Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party

  Andrea Bacigalupo;Gerard Socie;Edoardo Lanino;Arcangelo Prete

  268
  Citations

• A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.

  André Tichelli;Hubert Schrezenmeier;Gérard Socié;Judith Marsh

  261
  Citations

• Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome

  Austin G. Kulasekararaj;Austin G. Kulasekararaj;Jie Jiang;Jie Jiang;Alexander E. Smith;Alexander E. Smith;Azim M. Mohamedali;Azim M. Mohamedali

  259
  Citations